OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Webinar on Verified Antigen
Verified Antigen Webinar

Browse all lysates


spacer
OriGene in recent publications
Ginger Compound [6]-Shogaol and Its Cysteine-Conjugated Metabolite (M2) Activate Nrf2 in Colon Epithelial Cells in Vitro and in Vivo Chem. Res. Toxicol. Sep 2014 []

Hepatitis C Virus Subverts Liver-Specific miR-122 to Protect the Viral Genome from Exoribonuclease Xrn2 Cell Host Microbe Aug 2014 []

Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas Cancer Res. Aug 2014 []

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study Alzheimers Dement Aug 2014 []

View All Citations >>

spacer

56 Lysate belong to family "ion channels: cys-loop receptors"

divider

  Page: 1 of 3 
Direct Download
spacer
SKUAccnSymbolDescriptionShipping
LY400062NM_000171GLRA1Transient overexpression lysate of glycine receptor, alpha 1 (GLRA1), transcript variant 2 5 days
LY400246NM_000742CHRNA2Transient overexpression lysate of cholinergic receptor, nicotinic, alpha 2 (neuronal) (CHRNA2) 5 days
LY400248NM_000744CHRNA4Transient overexpression lysate of cholinergic receptor, nicotinic, alpha 4 (CHRNA4) 5 days
LY400250NM_000746CHRNA7Transient overexpression lysate of cholinergic receptor, nicotinic, alpha 7 (CHRNA7) 5 days
LY400251NM_000748CHRNB2Transient overexpression lysate of cholinergic receptor, nicotinic, beta 2 (neuronal) (CHRNB2) 5 days
LY400252NM_000749CHRNB3Transient overexpression lysate of cholinergic receptor, nicotinic, beta 3 (CHRNB3) 5 days
LY400253NM_000750CHRNB4Transient overexpression lysate of cholinergic receptor, nicotinic, beta 4 (CHRNB4) 5 days
LY400282NM_000806GABRA1Transient overexpression lysate of gamma-aminobutyric acid (GABA) A receptor, alpha 1 (GABRA1), transcript variant 1 5 days
LY400284NM_000810GABRA5Transient overexpression lysate of gamma-aminobutyric acid (GABA) A receptor, alpha 5 (GABRA5), transcript variant 1 5 days
LY400286NM_000812GABRB1Transient overexpression lysate of gamma-aminobutyric acid (GABA) A receptor, beta 1 (GABRB1) 5 days
LY400287NM_000813GABRB2Transient overexpression lysate of gamma-aminobutyric acid (GABA) A receptor, beta 2 (GABRB2), transcript variant 2 5 days
LY400288NM_000814GABRB3Transient overexpression lysate of gamma-aminobutyric acid (GABA) A receptor, beta 3 (GABRB3), transcript variant 1 5 days
LY400754NM_002063GLRA2Transient overexpression lysate of glycine receptor, alpha 2 (GLRA2), transcript variant 1 5 days
LY401349NM_004198CHRNA6Transient overexpression lysate of cholinergic receptor, nicotinic, alpha 6 (CHRNA6) 5 days
LY401542NM_004961GABRETransient overexpression lysate of gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE) 5 days
LY401955NM_006529GLRA3Transient overexpression lysate of glycine receptor, alpha 3 (GLRA3), transcript variant 1 5 days
LY402600NM_017581CHRNA9Transient overexpression lysate of cholinergic receptor, nicotinic, alpha 9 (CHRNA9) 5 days
LY402695NM_018558GABRQTransient overexpression lysate of gamma-aminobutyric acid (GABA) receptor, theta (GABRQ) 5 days
LY402789NM_020402CHRNA10Transient overexpression lysate of cholinergic receptor, nicotinic, alpha 10 (CHRNA10) 5 days
LY403235NM_033223GABRG3Transient overexpression lysate of gamma-aminobutyric acid (GABA) A receptor, gamma 3 (GABRG3) 5 days

 

pattern
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title